Trimetazidine
Trimetazidine

0.94
Cellular adjustment helps with cardiac energy metabolism during periods of increased metabolic demand.


Ingredient
Availability
In Stock
Delivery Time
Airmail (14-21 days) | Trackable (5-9 days)
Shipped in a discreet, unmarked envelope with all required documents enclosed.

Product Sheet

Active Ingredient(s)
Trimetazidine
Reference Brand
Vastarel
Product Origin
Generic Product
Reference Manufacturer
Servier
Product Form
Tablet, Extended-Release Capsule
Regulatory Classification
Rx
Primary Category
Heart & Blood Pressure
Product Category
Antianginal
Pharmacological Class
p-FAT Inhibitor
Clinical Indications
Manufacturer Description
Utilized for angina pectoris to manage myocardial metabolism and support heart function.
Mechanism of Action
Trimetazidine inhibits the beta-oxidation of fatty acids in heart cells. This shifts energy production toward glucose oxidation, which requires less oxygen and maintains ATP levels during periods of ischemia, protecting the heart muscle.
Route of Administration
Oral
Onset Time
2–4 weeks
Duration
12–24 hours
Contraindications
Parkinson's disease, Severe renal impairment, Hypersensitivity to trimetazidine
Severe Adverse Events
Parkinsonian symptoms, Angioedema, Severe cardiac arrhythmias — requires immediate medical attention
Common Side Effects
Dizziness, Headache, Nausea
Uncommon Side Effects
Abdominal pain, Rash, Diarrhea
Drug Interactions
Alcohol
Pregnancy Safety Warnings
FDA Category C: Use only if clearly needed. Breastfeeding: Not recommended.
Age Restrictions
Safety and efficacy in pediatric patients have not been established.
Storage Guidelines
Store below 30°C.
Related Products
Vastarel, Imdur, Cardizem
Information related to Trimetazidine is compiled and periodically reviewed with reference to established medical sources and prescribing guidance. Content is provided for general reference and should be confirmed with a registered healthcare professional before use.
Categories
Where to access Contraceptive Pills - Levlen Generic